Literature DB >> 9231662

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

S Lehto1, T Rönnemaa, S M Haffner, K Pyörälä, V Kallio, M Laakso.   

Abstract

Patients with NIDDM are at increased risk for coronary heart disease (CHD). However, information on the predictive value of cardiovascular risk factors and the degree of hyperglycemia with respect to the risk for CHD in diabetic patients is still limited. Therefore, we carried out a prospective study on risk factors for CHD, including a large number of NIDDM patients. At baseline, risk factor levels of CHD were determined in 1,059 NIDDM patients (581 men and 478 women), aged from 45 to 64 years. These patients were followed up to 7 years with respect to CHD events. Altogether, 158 NIDDM patients (97 men [16.7%] and 61 women [12.8%]) died of CHD and 256 NIDDM patients (156 men [26.8%] and 100 women [20.9%]) had a serious CHD event (death from CHD or nonfatal myocardial infarction). A previous history of myocardial infarction, low HDL cholesterol level (<1.0 mmol/l), high non-HDL cholesterol (> or =5.2 mmol/l), high total triglyceride level (>2.3 mmol/l), and high fasting plasma glucose (>13.4 mmol/l) were associated with a twofold increase in the risk of CHD mortality or morbidity, independently of other cardiovascular risk factors. High calculated LDL cholesterol level (> or =4.1 mmol/l) was significantly associated with all CHD events. The simultaneous presence of high fasting glucose (>13.4 mmol/l) with low HDL cholesterol, low HDL-to-total cholesterol ratio, or high total triglycerides further increased the risk for CHD events up to threefold. Our 7-year follow-up study provides evidence that dyslipidemia and poor glycemic control predict CHD mortality and morbidity in patients with NIDDM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231662     DOI: 10.2337/diab.46.8.1354

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  55 in total

Review 1.  The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies.

Authors:  Luke W Arnold; Zhiqiang Wang
Journal:  Rev Diabet Stud       Date:  2014-08-10

2.  Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.

Authors:  A I Adler; I M Stratton; H A Neil; J S Yudkin; D R Matthews; C A Cull; A D Wright; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

Review 3.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Effects of aerobic exercise on non-high-density lipoprotein cholesterol in children and adolescents: a meta-analysis of randomized controlled trials.

Authors:  George A Kelley; Kristi S Kelley
Journal:  Prog Cardiovasc Nurs       Date:  2008

5.  Predictors of poor glycaemic control in older patients with type 2 diabetes mellitus.

Authors:  Shariff-Ghazali Sazlina; Ismail Mastura; Ai Theng Cheong; Adam Bujang Mohamad; Haniff Jamaiyah; Ping Yein Lee; Syed Abdul Rahman Syed Alwi; Boon How Chew
Journal:  Singapore Med J       Date:  2015-05       Impact factor: 1.858

Review 6.  Strategies for the management of diabetic dyslipidaemia.

Authors:  M R Taskinen
Journal:  Drugs       Date:  1999       Impact factor: 9.546

7.  Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.

Authors:  Anne Hiukka; Jamila Fruchart-Najib; Eeva Leinonen; Hannele Hilden; Jean-Charles Fruchart; Marja-Riitta Taskinen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

8.  Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes.

Authors:  B Charbonnel; G Schernthaner; P Brunetti; D R Matthews; R Urquhart; M H Tan; M Hanefeld
Journal:  Diabetologia       Date:  2005-05-12       Impact factor: 10.122

9.  Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.

Authors:  M B Schulze; I Shai; J E Manson; T Li; N Rifai; R Jiang; F B Hu
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

10.  Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.